Faculty Spotlight: Melissa Kay, PhD, MS, MPH, RD
This week’s Faculty Spotlight shines on pediatrician Melissa Kay, PhD, MS, MPH, RD. Kay talks to us about how she first became interested in pediatric nutrition while pursuing dual master's degrees in Public Health and Food Policy & Applied Nutrition at Tufts University.
Welcome New Pediatrics Faculty Members
Welcome to the newest faculty members of the Department of Pediatrics! We are fortunate to welcome 13 new primary faculty members and 3 clinical associates this academic year.
Faculty Spotlight: Jeffrey Brian Russ, MD, PhD
Jeffrey Russ, MD, PhD has had a lifelong interest in both neuroscience and neurology, and it was his interest in brain development that led him to a clinical interest in pediatric neurology.
New Pediatrics Fellows (2022 - 2023)
The Duke Department of Pediatrics fellowship programs are designed to provide outstanding training to prepare our fellows to excel as sub-specialty clinicians, researchers, and teachers within the field of pediatrics.
CHDI announces Child Health Equity Program awardees
The Duke Children’s Health and Discovery Initiative (CHDI) is pleased to announce the CHDI-CTSI Child Health Equity Program awardees.
Congratulations to the 2022 LEADER Alumni!
Congratulations to the 2022 LEADER program graduates from Duke Pediatrics, including Elizabeth Erickson, MD (General Pediatrics and Adolescent Health) and Shatha Wajih Yousef, MBBS (Pulmonary and S
Stark receives Thrasher Research Fund Early Career Award
Ashley Stark, MD, a rising second-year Neonatology fellow in the Duke Department of Pediatrics, was recently awarded a Thrasher Research Fund Early Career Award for her project entitled, Pharmacokinetics of Clonidine Administered in the Infant Population.
Rent awarded National Palliative Care Research Center's Kornfield Scholars Program grant
Sharla Rent, MD, assistant professor of pediatrics in the Division of Neonatology, was recently awarded a two-year career development grant from the National Palliative Care Research Center's Kornfeld Scholars Program.
Immune modulator drugs improved survival for people hospitalized with COVID-19
A large randomized, placebo-controlled clinical trial led by the National Institutes of Health with support from the Duke Clinical Research Institute shows that treating adults hospitalized with COVID-19 with infliximab or abatacept – drugs widely used to treat certain autoimmune diseases – substantially improved clinical status and reduced deaths.
Juneteenth: Message from the Chair
Juneteenth, or June 19, marks the date in 1865 when word finally reached communities of enslaved people in Texas that the Civil War had ended and they were freed from slavery—two and a half years following President Lincoln’s Emancipation Proclamation.